| Literature DB >> 26925309 |
Yan Gao1, Wei Chen2, Yue-Jv Liu2, Xu Li2, Hai-Li Wang2, Zhao-Yu Chen3.
Abstract
Background. Plate fixation and intramedullary fixation are the most commonly used surgical treatment options for mid-shaft clavicle fractures; the latter method has demonstrated better performance in some studies. Objectives. Our aim was to critically review and summarize the literature comparing the outcomes of mid-shaft clavicle fracture treatment with plate fixation or intramedullary fixation to identify the better approach. Search Methods. Potential academic articles were identified from the Cochrane Library, MEDLINE (1966-2015.5), PubMed (1966-2015.5), EMBASE (1980-2015.5) and ScienceDirect (1966-2015.5). Gray studies were identified from the references of the included literature. Selection Criteria. Randomized controlled trials (RCTs) and non-RCTs comparing plate fixation and intramedullary fixation for mid-shaft clavicle fracture were included. Data Collection and Analysis. Two reviewers performed independent data abstraction. The I (2) statistic was used to assess heterogeneity. A fixed- or random-effects model was used for the meta-analysis. Results. Six RCTs and nine non-RCTs were retrieved, including 513 patients in the intramedullary fixation group and 521 patients in the plating group. No significant differences in terms of the union rate and shoulder function were found between the groups. Patients in the intramedullary fixation group had a shorter operative time, less blood loss, smaller wound size, and shorter union time than those in the plating group. With respect to complications, significant differences were identified for all complications and major complications (wound infection, nonunion, implant failures, transient brachial plexopathy, and pain after 6 months). Similar secondary complications (symptomatic hardware, hardware irritation, prominence, numbness, hypertrophic callus) were observed in both groups. Conclusions. Intramedullary fixation may be superior to plate fixation in the treatment of mid-shaft clavicle fractures, with similar performance in terms of the union rate and shoulder function, better operative parameters and fewer complications.Entities:
Keywords: Intramedullary fixation; Meta-analysis; Mid-shaft clavicle fractures; Plating fixation
Year: 2016 PMID: 26925309 PMCID: PMC4768682 DOI: 10.7717/peerj.1540
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Flow chart showing identification and selection of cases.
Characteristics of included studies.
| Study | Time | Type | Invention | Age(years) | Gender(F/M) | Follow-up(months) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IF | PF | IF | PF | IF | PF | IF | PF | |||
| Lee YS et al. | 2007 | RCT | Knowles pin | DCP | 60.4(50–81) | 56.7(52–79) | 32(19/13) | 30(17/13) | 30 | |
| Lee YS et al. | 2008 | RCT | Knowles pin | DCP, tubular and reconstruction plate | 40.1 | 38.2 | 56(19/37) | 32(12/20) | 12 | |
| Ferran NA et al. | 2010 | RCT | Rockwood Pin | LC-DCP | 23.8(13–42) | 35.4(16–53) | 17(14/3) | 15(13/2) | 12.7 ± 3.5 | 12.1 ± 5.7 |
| Assobhi JE et al. | 2011 | RCT | Titanium elastic nail | 3.5 mm reconstruction plate | 30.3 ± 4.8 | 32.6 ± 5.9 | 19(16/3) | 19(17/2) | 14.5 ± 1.5 | 18.6 ± 3.8 |
| Narsaria N et al. | 2014 | RCT | Titanium elastic nail | 3.5 mm DCP | 38.9 ± 9.1 | 40.3 ± 11.2 | 33(9/24) | 32(6/26) | 24 | |
| Saha P et al. | 2014 | RCT | Titanium elastic nail | Locking plate | 33.3 ± 11.8 | 33.0 ± 12.6 | 34(4/30) | 37(7/30) | 24.6 ± 2.4 | 25.1 ± 3.3 |
| S, Thyagarajan D et al. | 2009 | nRCT | Rockwood Pin | LC-DCP | 28(15–56) | 32.1(17–46) | 17(1/16) | 17(2/15) | 5.9(4–11) | |
| Liu HH et al. | 2010 | nRCT | Titanium elastic nail | Reconstruction LCP | 33.6 ± 13.5 | 31.7 ± 9.7 | 51(19/32) | 59(30/29) | 17.7(12–27) | |
| Kleweno CP et al. | 2011 | nRCT | Rockwood Pin | Reconstruction plate or locking plate | 35(16–56) | 28(16–46) | 18(3/15) | 14(4/10) | 8(3–28) | 17(4–58) |
| Fu TH et al. | 2012 | nRCT | Knowles pin | Reconstruction plate | 35.2 ± 14.5 | 39.9 ± 14.8 | 53(15/38) | 40(17/33) | 15(12–153) | 14(12–92) |
| Chen YF et al. | 2012 | nRCT | Titanium elastic nail | 3.5 mm reconstruction plates | 38(26.5–58) | 46.5(36.5–58.8) | 25(15/10) | 32(14/18) | 12 | |
| Tarng YW et al. | 2012 | nRCT | Titanium elastic nail | Reconstruction plates | 34.3(20–59) | 36.5(19–63) | 57(16/41) | 84(23/61) | 24 | |
| Wijdicks FJ et al. | 2012 | nRCT | Titanium elastic nail | Reconstruction plate or locking plate | 39.4 ± 14.1 | 33.1 ± 15.6 | 43(10/33) | 47(14/33) | 6(5–12) | 8(2–15) |
| Wenninger JJ et al. | 2013 | nRCT | Rigid Hagie pin | 3.5 mm reconstruction plate or LC-DCP | 25.2(18–51) | 26.9(20–49) | 33(1/32) | 29(3/26) | 12 | |
| Jones LD et al. | 2014 | nRCT | Titanium elastic nail | N | N | N | 25 | 24 | 30(12–54) | |
Quality assessment for randomized trials.
| Quality assessment for randomized trials | Lee YS (2007) | Lee YS | Ferran NA | Assobhi JE | Narsaria N | Saha P |
|---|---|---|---|---|---|---|
| Was the assigned treatment adequately concealed prior to allocation? | 1 | 1 | 2 | 2 | 2 | 1 |
| Were the outcomes of participants who withdrew described and included in the analysis? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were the treatment and control group comparable at entry? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were the outcome assessors blinded to treatment status? | 2 | 0 | 2 | 0 | 0 | 0 |
| Were the participants blind to assignment status after allocation? | 0 | 0 | 0 | 0 | 0 | 0 |
| Were the treatment providers blind to assignment status? | 0 | 0 | 0 | 0 | 0 | 0 |
| Were care programs, other than the trial options, identical? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were the inclusion and exclusion criteria clearly defined? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were the interventions clearly defined? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were the outcome measures used clearly defined? | 2 | 2 | 2 | 2 | 2 | 2 |
| Were diagnostic tests used in outcome assessment clinically useful? | 2 | 2 | 2 | 2 | 2 | 2 |
| Was the surveillance active, and of clinically appropriate duration? | 2 | 2 | 2 | 2 | 2 | 2 |
Figure 2Quality assessment for non-randomized trials.
Figure 3Forest plot showing blood loss in the two groups.
Figure 4Forest plot showing operative time in the two groups.
Figure 5Forest plot showing wound size in the two groups.
Figure 6Forest plot showing hospital stays in the two groups.
Figure 7Forest plot showing union rate in the two groups.
Figure 8Forest plot showing union time in the two groups.
Figure 9Forest plot showing shoulder score in the two groups.
Figure 10Forest plot showing complications in the two groups.